Skip to content

IsraelNational.News

  • Israel
  • Entertain
  • Tech
  • Sports
  • World
  • Business
  • Science
  • Health

IsraelNational.News

  • Israel
  • Entertain
  • Tech
  • Sports
  • World
  • Business
  • Science
  • Health

Nasdaq: OCGN

The European Commission provides the Ocugen Orphan Medicinal Product Specification for a gene therapy product candidate, OCU400, for the treatment of both Retinitis Pigmentosa and Congenital Leber Amaberosis

The European Commission provides the Ocugen Orphan Medicinal Product Specification for a gene therapy product candidate, OCU400, for the treatment of both Retinitis Pigmentosa and Congenital Leber Amaberosis

footer

  • About
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • DMCA
  • Disclaimer
  • Sitemap
  • News-Sitemap
© 2025 IsraelNational.News